Singapore's Temasek has a sticky China problem
The author is a Reuters Breakingviews columnist. The opinions expressed are his own. Updates to add graphics.
By Anshuman Daga
SINGAPORE, July 10 (Reuters Breakingviews) -There's no hiding for Temasek. The Singapore sovereign investor's portfolio value edged up 1.8% to S$389 billion ($288 billion) in the year to March. That's after dipping in the prior year, but the group's heavy focus on China is a drag. For CEO Dilhan Pillay, it is tricky to pull back from the world's second-largest economy to shore up returns.
Like other global investors, the geographic split of Temasek's assets is changing fast. Its exposure to the Americas at 22% of its portfolio by underlying assets overtook China for the first time in a decade to be second only to Singapore. The share of the People's Republic fell to 19%, 3 percentage points lower than in 2022, but Temasek remains one of the largest institutional investors in the country. By contrast, China accounts for less than 3% of the MSCI All Country World Index .MIWD00000PUS.
A good chunk of Temasek's China exposure is stuck in private investments.Ant is one of them.The Jack Ma-founded fintech giant is worth perhaps a quarter of the $315 billion valuation it flaunted before it tried and failed to float in 2020. Another is a decade-old minority stake in health and beauty company A.S. Watson Group, a unit majority-owned by CK Hutchison 0001.HK. Temasek's subsidiary, PSA, also owns a multi-billion-dollar 20% stake in the Hong Kong-based conglomerate's ports business and has struggled to offload it.
Temasek's public stakes in the country include out-of-vogue tech companies Tencent 0700.HK and Alibaba 9988.HK. And while its holdings in banks such as Industrial and Commercial Bank of China 601398.SS have fared well of late, the state-backed lender is among those bearing the brunt of the country's debt worries. Temasek's Deputy CEO Chia Song Hwee told Breakingviews that "reshaping" the large China portfolio, including focusing on faster-growth sectors, would take time.
Awkwardly, that task is further complicated by Singapore's close financial relationship with its large Asian neighbour. Were Temasek to pare its exposure to China as much as many U.S. funds have done, it would risk a backlash from Beijing. Many in Singapore still believe in China's prospects beyond the short term, and sovereign investors are known for taking a long view. Temasek's hands, though, appear somewhat tied.
Follow @anshumandaga on X
CONTEXT NEWS
Singapore state investor Temasek on July 9 reported a net portfolio value of S$389 billion ($288 billion) for the financial year to the end of March, a 1.8% increase from the previous year.
($1 = 1.3507 Singapore dollars)
Temasek's portfolio value is rising again Temasek's portfolio value is rising again https://www.reuters.com/graphics/BRV-BRV/zjvqynoejvx/chart.png
Temasek's China portfolio holdings decline Temasek's China portfolio holdings decline https://www.reuters.com/graphics/BRV-BRV/gdvzmkbwjpw/chart.png
Editing by Una Galani and Aditya Srivastav
Related Assets
Latest News
Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.
All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.
Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.
